Pfizer hikes full-year outlook as newer products grow, taps company veteran as new CFO

Pfizer named Cecile Guegan, a 20-year company veteran, as its new chief financial officer this month. The appointment comes as the drugmaker raised its full-year outlook, citing growth from newer products. Guegan previously held various leadership roles at Pfizer, and her promotion signals continuity in the finance department amid a strategic focus on expanding its portfolio.